Mylan’s EpiPen price hike was a scheme to stifle competition, rival claims

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by Super_Jambo on Wednesday April 26, 2017 @09:38AM (#14202799)

Ah yes "free markets".

[ Parent | on HN ]

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by scaryspooky on Wednesday April 26, 2017 @09:57AM (#14202961)

Except there is very little "free market" about the medical device industry, which is heavily regulated and also able to abuse the patent system.

[ Parent | on HN ]

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by cmdrfred on Wednesday April 26, 2017 @10:03AM (#14203006)

Probably the most regulated market we have.

[ Parent | on HN ]

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by Symmetry on Wednesday April 26, 2017 @10:41AM (#14203359)

Drugs combine the intensive quality regulations that medical devices have with production quotas so those probably edge out medical devices.

[ Parent | on HN ]

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by cmdrfred on Wednesday April 26, 2017 @02:52PM (#14205863)

Isn't this a medical device that contains a drug?

[ Parent | on HN ]

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by setum on Wednesday April 26, 2017 @10:09AM (#14203073)

It's hardly a "free market" - the barrier to entry is very high due FDA approval process which can take decades and millions of dollars.

[ Parent | on HN ]